Innocenti, G.P.; Santinelli, L.; Laghi, L.; Borrazzo, C.; Pinacchio, C.; Fratino, M.; Celani, L.; Cavallari, E.N.; Scagnolari, C.; Frasca, F.;
et al. Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial. Metabolites 2020, 10, 274.
https://doi.org/10.3390/metabo10070274
AMA Style
Innocenti GP, Santinelli L, Laghi L, Borrazzo C, Pinacchio C, Fratino M, Celani L, Cavallari EN, Scagnolari C, Frasca F,
et al. Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial. Metabolites. 2020; 10(7):274.
https://doi.org/10.3390/metabo10070274
Chicago/Turabian Style
Innocenti, Giuseppe P., Letizia Santinelli, Luca Laghi, Cristian Borrazzo, Claudia Pinacchio, Mariangela Fratino, Luigi Celani, Eugenio N. Cavallari, Carolina Scagnolari, Federica Frasca,
and et al. 2020. "Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial" Metabolites 10, no. 7: 274.
https://doi.org/10.3390/metabo10070274
APA Style
Innocenti, G. P., Santinelli, L., Laghi, L., Borrazzo, C., Pinacchio, C., Fratino, M., Celani, L., Cavallari, E. N., Scagnolari, C., Frasca, F., Antonelli, G., Mastroianni, C. M., d’Ettorre, G., & Ceccarelli, G.
(2020). Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial. Metabolites, 10(7), 274.
https://doi.org/10.3390/metabo10070274
